Prevalence of transthyretin amyloid cardiomyopathy in pacemaker patients
Abstract Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is characterized by increased wall thickness, diastolic dysfunction and progressive heart failure symptoms. The disease may infiltrate the conduction system leading to conduction disturbances requiring an implantation of permanent cardiac...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2024-04-01
|
| Edice: | ESC Heart Failure |
| Témata: | |
| On-line přístup: | https://doi.org/10.1002/ehf2.14645 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
